BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3472523)

  • 1. Chain-shortening of prostaglandin F2 alpha by rat liver peroxisomes.
    Diczfalusy U; Alexson SE; Pedersen JI
    Biochem Biophys Res Commun; 1987 May; 144(3):1206-13. PubMed ID: 3472523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal chain-shortening of prostaglandin F2 alpha.
    Diczfalusy U; Alexson SE
    J Lipid Res; 1988 Dec; 29(12):1629-36. PubMed ID: 3244014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of prostaglandins D2 and F2 alpha in primary cultures of rat hepatocytes.
    Sago T; Nakayama R; Okumura T; Saito K
    Biochim Biophys Acta; 1986 Dec; 879(3):330-8. PubMed ID: 3465372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of metabolites from peroxisomal beta-oxidation of prostaglandins.
    Diczfalusy U; Alexson SE
    J Lipid Res; 1990 Feb; 31(2):307-14. PubMed ID: 2324649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.
    Diczfalusy U; Kase BF; Alexson SE; Björkhem I
    J Clin Invest; 1991 Sep; 88(3):978-84. PubMed ID: 1885782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisomal chain-shortening of thromboxane B2: evidence for impaired degradation of thromboxane B2 in Zellweger syndrome.
    Diczfalusy U; Vesterqvist O; Kase BF; Lund E; Alexson SE
    J Lipid Res; 1993 Jul; 34(7):1107-13. PubMed ID: 8371058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro formation of bile acids from di- and trihydroxy-5 beta-cholestanoic acid in human liver peroxisomes.
    Kase BF; Prydz K; Björkhem I; Pedersen JI
    Biochim Biophys Acta; 1986 Jun; 877(1):37-42. PubMed ID: 3013317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species differences in circulating prostaglandin metabolites. Relevance for the assay of prostaglandin release.
    Granström E; Kindahl H
    Biochim Biophys Acta; 1982 Dec; 713(3):555-69. PubMed ID: 6960930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of prostaglandin D2 in isolated rat lung: the stereospecific formation of 9 alpha,11 beta-prostaglandin F2 from prostaglandin D2.
    Hayashi H; Ito S; Watanabe K; Negishi M; Shintani T; Hayaishi O
    Biochim Biophys Acta; 1987 Feb; 917(3):356-64. PubMed ID: 3467796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 9 alpha, 11 beta-prostaglandin F2 by stereospecific antibody in various rat tissues.
    Hayashi H; Ito S; Tanaka T; Negishi M; Kawabe H; Yokohama H; Watanabe K; Hayaishi O
    Prostaglandins; 1987 Apr; 33(4):517-30. PubMed ID: 3474704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid synthesis in rat liver peroxisomes: metabolism of 26-hydroxycholesterol to 3 beta-hydroxy-5-cholenoic acid.
    Krisans SK; Thompson SL; Pena LA; Kok E; Javitt NB
    J Lipid Res; 1985 Nov; 26(11):1324-32. PubMed ID: 4067421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water- and solute-accessible spaces of purified peroxisomes. Evidence that peroxisomes are permeable to NAD+.
    Van Veldhoven P; Debeer LJ; Mannaerts GP
    Biochem J; 1983 Mar; 210(3):685-93. PubMed ID: 6870803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copurification of prostaglandin F2 alpha receptors with rat uterine plasma membranes.
    Lintner F; Toth M; Hertelendy F
    Experientia; 1983 Oct; 39(10):1102-3. PubMed ID: 6311608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of cholic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid by rat liver peroxisomes.
    Kase F; Björkhem I; Pedersen JI
    J Lipid Res; 1983 Dec; 24(12):1560-7. PubMed ID: 6668450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic metabolism of orally administered prostaglandin F2 alpha in suckling and weanling rats.
    Bedrick AD; Koldovský O
    Biol Neonate; 1985; 48(6):351-6. PubMed ID: 3866612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholest-24-enoic acid as an intermediate in the peroxisomal conversion of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid to cholic acid.
    Ostlund Farrants AK; Björkhem I; Pedersen JI
    Biochim Biophys Acta; 1989 Apr; 1002(2):198-202. PubMed ID: 2930767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemistry of intermediates in the conversion of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid to cholic acid by rat liver peroxisomes.
    Une M; Izumi N; Hoshita T
    J Biochem; 1993 Feb; 113(2):141-3. PubMed ID: 8468319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of intermediates in the peroxisomal beta-oxidation of linoleic acid.
    Diczfalusy U; Alexson SE; Sisfontes L; Olund J; Björkhem I
    Biochim Biophys Acta; 1990 Apr; 1043(2):182-8. PubMed ID: 2317529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer.
    Liston TE; Roberts LJ
    J Biol Chem; 1985 Oct; 260(24):13172-80. PubMed ID: 3863815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of cholic acid with taurine and glycine by rat liver peroxisomes.
    Kase BF; Prydz K; Björkhem I; Pedersen JI
    Biochem Biophys Res Commun; 1986 Jul; 138(1):167-73. PubMed ID: 3741411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.